Because I knew it better before, you provided this, we have studied it repeatedly before, and we have also talked about it. Because we recently focused on learning the new guide and belyumumab, and asked the British professor who started this experiment to tell us. So we have learned this thoroughly, including the trial grouping and the situation of the combination medication at that time, and the patient's adverse reactions. Last week we invited the professor who was in charge of the trial to share this content with us. So we have been relatively speaking before. Although it is useless, it is because there is no medicine in our hands. However, for the medicine itself, the existing evidence-based medicine has been relatively fully understood.
正在翻译中..